CD8A and neoplasm: Nonetheless, although venushigh CD8+ T-cells were detected in mice receiving anti-PD-1, anti-CTLA-4, the anti-PD-1/4-1BB combination or anti-CD4 mAbs (Fig. 3), tumor growth was still not controlled in the anti-CTLA-4 group (Fig. 1).